• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX SANTA ROSA OVATION IX; MAIN BODY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX SANTA ROSA OVATION IX; MAIN BODY Back to Search Results
Model Number TV-AB2980-J
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Code Failure of Implant (1924)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The devices involved in this event will not be returned for evaluation and remain implanted in the patient.If additional information is obtained at a later time that is pertinent to this event, a follow-up report will then be submitted.Devices remain implanted in patient.
 
Event or Problem Description
The patient was initially treated for an abdominal aortic aneurysm (aaa) with the ovation ix abdominal aortic aneurysm stent.Approximately ten (10) months post initial procedure, the patient presented with a type ia endoleak.The physician plans to re-intervene but surgery has not been scheduled.As of date, there have been no additional patient sequelae reported.
 
Event or Problem Description
The patient was initially treated for an abdominal aortic aneurysm (aaa) with the ovation ix abdominal aortic aneurysm stent.Approximately ten (10) months post initial procedure, the patient presented with a type ia endoleak.The physician plans to re-intervene but surgery has not been scheduled.As of date, there have been no additional patient sequelae reported.Subsequent to the initial report additional information was received that re-intervention was completed with coil placement in the open space and implant of a gore (non-endologix) cuff.The type ia endoleak was sealed and the patient was stable.
 
Additional Manufacturer Narrative
Clinical assessment of the reported event was unable to be completed due to a lack of receipt of relevant medical records and/or imaging.Requests were made; however, denied due to patient authorization requirements.As such, event determination, off label conditions, related patient harms and patient disposition could not be assessed.The manufacturing lot evaluation confirmed all devices met specifications prior to release.The device remains implanted; therefore, no device evaluation was completed.No additional investigation of this reported event is planned; however, if additional information pertinent to the incident is obtained, a follow-up report will be submitted.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.Corrections: result code remove 3233.Conclusion code remove 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVATION IX
Common Device Name
MAIN BODY
Manufacturer (Section D)
ENDOLOGIX SANTA ROSA
3910 brickway blvd
santa rosa CA 95403
MDR Report Key9508920
Report Number3008011247-2019-00181
Device Sequence Number2080038
Product Code MIH
UDI-Device IdentifierM701TVAB2980J1
UDI-Public+M701TVAB2980J1/$$3210928FS09251826N
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P120006
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date (Section B) 11/20/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/28/2021
Device Model NumberTV-AB2980-J
Device Catalogue NumberTV-AB2980-J
Device Lot NumberFS092518-26
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 11/20/2019
Supplement Date Received by Manufacturer11/20/2019
Initial Report FDA Received Date12/22/2019
Supplement Report FDA Received Date07/29/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
OVATION IX ILIAC LIMB FS052418-33.; OVATION IX ILIAC LIMB FS072618-26.
Outcome Attributed to Adverse Event Other; Required Intervention;
Patient Age78 YR
-
-